Details for 2023160271

Up to date per 01.04.2026

Actions

Title / Product Name

KAPSELFORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023160271

EP Publication Number

4233850

E-Number

1727975

Language

PCT Number

Publication Date

30.08.2023 A

02.10.2024 B1

Registration Date

02.10.2024

AT Publication Date

15.10.2024

Application Date

27.11.2019

Registration Number

Priorities

30.11.2018

201862773848 P

IPC

A61K 9/48 20060101AFI20230816BHEP

Maximum Duration of Protection

27.11.2039

Owner

ChemoCentryx, Inc.One Amgen Center Drive Thousand Oaks, CA 91320US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

LELETI, Manmohan Reddy California, 94568US

POWERS, Jay P California, 94044US

Information about Fees